SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
1-Year Return
4.68%
This Quarter Return
+13.27%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$437M
AUM Growth
+$49.4M
(+13%)
Cap. Flow
-$5.43M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
60.21%
Holding
38
New
7
Increased
8
Reduced
12
Closed
7
Top Buys
| 1 |
Labcorp
LH
|
$17.5M |
| 2 |
Edwards Lifesciences
EW
|
$13M |
| 3 |
Illumina
ILMN
|
$9.6M |
| 4 |
Tenet Healthcare
THC
|
$9.56M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$4.7M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$24.6M |
| 2 |
Biogen
BIIB
|
$11.1M |
| 3 |
Cigna
CI
|
$9.37M |
| 4 |
Merck
MRK
|
$5.98M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$4.53M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioNTech
BNTX
$24.7B
| $3.57M | 0.82% |
+23,738
| New | +$3.57M |
|
27
PTC Therapeutics
PTCT
$4.51B
| $3.31M | 0.76% |
86,692
| – | – |
|
28
Acadia Pharmaceuticals
ACAD
$4.32B
| $2.96M | 0.68% |
+185,835
| New | +$2.96M |
|
|
CTLT
29
DELISTED
CATALENT, INC.
CTLT
| $2.48M | 0.57% |
+55,000
| New | +$2.48M |
|
30
Vir Biotechnology
VIR
$710M
| $2.27M | 0.52% |
89,808
| – | – |
|
31
Ultragenyx Pharmaceutical
RARE
$3.01B
| $2.11M | 0.48% |
45,520
| – | – |
|
32
Alnylam Pharmaceuticals
ALNY
$59.5B
| – | – |
-6,921
| Closed | -$1.39M |
|
33
Embecta
EMBC
$836M
| – | – |
-5,246
| Closed | -$151K |
|
34
Novavax
NVAX
$1.23B
| – | – |
-56,735
| Closed | -$1.03M |
|
35
Rigel Pharmaceuticals
RIGL
$723M
| – | – |
-134,690
| Closed | -$1.59M |
|
|
SAGE
36
DELISTED
Sage Therapeutics
SAGE
| – | – |
-115,696
| Closed | -$4.53M |
|
37
Universal Health Services
UHS
$11.8B
| – | – |
-27,077
| Closed | -$2.39M |
|
|
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-68,612
| Closed | -$3.19M |
|